Evidence map›Paper›PMID 35054976›Full record

ReviewInternational journal of molecular sciences2022

A New Player in the Hippocampus: A Review on VGLUT3+ Neurons and Their Role in the Regulation of Hippocampal Activity and Behaviour.

Csilla Lea Fazekas, Adrienn Szabó, Bibiána Török, Krisztina Bánrévi, Pedro Correia, Tiago Chaves, Stéphanie Daumas, Dóra Zelena

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. μ-Opioid Receptor Modulation of the Glutamatergic/GABAergic Midbrain Inputs to the Mouse Dorsal Hippocampus.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Csilla Lea FazekasInstitute of Experimental Medicine, 1083 Budapest, Hungary.
Adrienn SzabóInstitute of Experimental Medicine, 1083 Budapest, Hungary.
Bibiána TörökInstitute of Experimental Medicine, 1083 Budapest, Hungary.
Krisztina BánréviInstitute of Experimental Medicine, 1083 Budapest, Hungary.
Pedro CorreiaInstitute of Experimental Medicine, 1083 Budapest, Hungary.ORCID 0000-0002-4410-9855
Tiago ChavesInstitute of Experimental Medicine, 1083 Budapest, Hungary.
Stéphanie DaumasNeuroscience Paris Seine-Institut de Biologie Paris Seine (NPS-IBPS) INSERM, Sorbonne Université, CNRS, 75005 Paris, France.
Dóra ZelenaInstitute of Experimental Medicine, 1083 Budapest, Hungary.
Semmelweis University · HUHUN-REN Institute of Experimental Medicine · HUCentre National de la Recherche Scientifique · FR

Funding

Ministry for Innovation and Technology in Hungary Thematic Excellence Program 2021 Health Sub-programmeNational Research, Development and Innovation Office K141934, K138763 and K 120311
6 · The paper itself

Abstract

Glutamate is the most abundant excitatory amino acid in the central nervous system. Neurons using glutamate as a neurotransmitter can be characterised by vesicular glutamate transporters (VGLUTs). Among the three subtypes, VGLUT3 is unique, co-localising with other "classical" neurotransmitters, such as the inhibitory GABA. Glutamate, manipulated by VGLUT3, can modulate the packaging as well as the release of other neurotransmitters and serve as a retrograde signal through its release from the somata and dendrites. Its contribution to sensory processes (including seeing, hearing, and mechanosensation) is well characterised. However, its involvement in learning and memory can only be assumed based on its prominent hippocampal presence. Although VGLUT3-expressing neurons are detectable in the hippocampus, most of the hippocampal VGLUT3 positivity can be found on nerve terminals, presumably coming from the median raphe. This hippocampal glutamatergic network plays a pivotal role in several important processes (e.g., learning and memory, emotions, epilepsy, cardiovascular regulation). Indirect information from anatomical studies and KO mice strains suggests the contribution of local VGLUT3-positive hippocampal neurons as well as afferentations in these events. However, further studies making use of more specific tools (e.g., Cre-mice, opto- and chemogenetics) are needed to confirm these assumptions.

Indexed as

AnimalsBiomarkersElectrophysiological PhenomenaGene Expression RegulationGene Knockdown TechniquesGlutamic AcidHippocampusHumansMiceMice, KnockoutNeurotransmitter AgentsPyramidal CellsSignal TransductionSynaptic TransmissionVesicular Glutamate Transport ProteinsBiomarkersGlutamic AcidNeurotransmitter AgentsSLC17A8 protein, humanVesicular Glutamate Transport Proteinscardiovascular regulationemotionshippocampuslearning and memorysensory processesstressvesicular glutamate transporter

Identifiers

PMID35054976
PMCPMC8775679
OpenAlexW4205180374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.